IL6 and Alzheimer disease: Elevated levels of typical inflammatory factors, such as IL-1β, IL-6, and TNF-α, were all significantly decreased in AD mouse brain after OT administration (Figure 5F-G and Figure S8), further supporting efficient clearance of Aβ through improved glymphatic drainage.